See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related research Videos on Diabetes Health TV

FDA

Page 2
FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17
Feb 4, 2014 | 
The U.S. Food and Drug Administration has approved the expanded use of the Dexcom G4 Platinum Continuous Glucose Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood glucose levels in people with diabetes, had been approved for patients ages 18 and older.
FDA Proposes Separate Guidelines for Home vs. Clinical Glucose Meters
Jan 23, 2014 | 
The Food and Drug Administration is proposing separate guidelines for over-the-counter blood glucose meters compared to those used at the doctor's office or in other healthcare settings.
DHTV
Popular
Top Rated

Related research Videos on Diabetes Health TV

FDA Opens Way for Diabetic Macular Edema Device
Jan 1, 2014 | 
The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a new treatment for diabetic macular edema to reach the U.S. market.
Is High Fructose Corn Syrup “the New Trans Fat"?
Dec 13, 2013 | 
The non-profit consumer action group Citizens for Health earlier this month called on the Food and Drug Administration to do its part in raising awareness of the dangers of high fructose corn syrup by making an official statement recognizing the sweetener as an unsafe addition to the nation's food supply.
FDA Clears Novo's Kid-Friendly Insulin Pen
Aug 22, 2013 | 
The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on the market to combine half-unit dosing with a memory function to help patients manage their diabetes.
FDA Approves Invokana, a New Type 2 Drug
Jun 27, 2013 | 
A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works by blocking re-absorption of glucose by the kidneys and stimulating urination, which removes glucose from the bloodstream.
12th Q&A With Dr. Bernstein
Jun 12, 2013 | 
Can Januvia Trigger Cancer Symptoms?
Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.